Does Psychostimulant Use Increase Cardiovascular Risk in Children with ADHD?

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern. The results of the first nationwide study of the cardiovascular safety of stimulants in children and adolescents are published in Journal of Child and Adolescent Psychopharmacology (JCAP) (http://www.liebertpub.com/jcap), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The article is available free on the JCAP (http://online.liebertpub.com/doi/full/10.1089/cap.2014.0020) website.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...